Browse > Article
http://dx.doi.org/10.3345/kjp.2015.58.6.224

Thyroid dysfunction in very low birth weight preterm infants  

Lee, Ji Hoon (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine)
Kim, Sung Woo (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine)
Jeon, Ga Won (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine)
Sin, Jong Beom (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.58, no.6, 2015 , pp. 224-229 More about this Journal
Abstract
Purpose: Thyroid dysfunction is common in preterm infants. Congenital hypothyroidism causes neurodevelopmental impairment, which is preventable if properly treated. This study was conducted to describe the characteristics of thyroid dysfunction in very low birth weight infants (VLBWIs), evaluate risk factors of hypothyroidism, and suggest the reassessment of thyroid function with an initially normal thyroid-stimulating hormone (TSH) as part of a newborn screening test. Methods: VLBWIs (January 2010 to December 2012) were divided into two groups according to dysfunction-specific thyroid hormone replacement therapy, and associated factors were evaluated. Results: Of VLBWIs, 246 survivors were enrolled. Only 12.2% (30/246) of enrolled subjects exhibited thyroid dysfunction requiring thyroid hormone replacement. Moreover, only one out of 30 subjects who required thyroid hormone treatment had abnormal thyroid function in the newborn screening test with measured TSH. Most of the subjects in the treatment group (22/30) exhibited delayed TSH elevation. Gestational age, Apgar score, antenatal steroids therapy, respiratory distress syndrome, patent ductus arteriosus, sepsis, intraventricular hemorrhage, postnatal steroids therapy, and duration of mechanical ventilation did not differ between the two groups. Birth weight was smaller and infants with small for gestational age were more frequent in the treatment group. Conclusion: Physicians should not rule out suggested hypothyroidism, even when thyroid function of a newborn screening test is normal. We suggest retesting TSH and free thyroxine in high risk preterm infants with an initially normal TSH level using a newborn screening test.
Keywords
Congenital hypothyroidism; Neonatal screening; Premature infant; Thyroid function tests; Very low birth weight infant;
Citations & Related Records
연도 인용수 순위
  • Reference
1 American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-303.   DOI
2 Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-13.   DOI
3 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.   DOI
4 Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers-Schokking JJ, Murphy N, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004;89:5314-20.   DOI
5 Vigone MC, Caiulo S, Di Frenna M, Ghirardello S, Corbetta C, Mosca F, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 2014;164:1296-302.   DOI
6 Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004;144:747-52.   DOI
7 Carrascosa A, Ruiz-Cuevas P, Clemente M, Salcedo S, Almar J. Thyroid function in 76 sick preterm infants 30-36 weeks: results from a longitudinal study. J Pediatr Endocrinol Metab 2008;21: 237-43.
8 van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol 2004;9:3-11.   DOI
9 Guy VV, Johnny D. Disorders of the thyroid in the newborn and infant. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia (PA): Saunders, 2014:186-208.
10 Lubchenco LO, Hansman C, Dressler M, Boyd E. Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800.
11 Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65.   DOI
12 Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.   DOI
13 Delahunty C, Falconer S, Hume R, Jackson L, Midgley P, Mirfield M, et al. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. J Clin Endocrinol Metab 2010;95:4898-908.   DOI
14 An international classification of retinopathy of prematurity. Pediatrics 1984;74:127-33.
15 Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-31.   DOI
16 Chung ML, Yoo HW, Kim KS, Lee BS, Pi SY, Lim G, et al. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome. J Pediatr Endocrinol Metab 2013;26:449-55.
17 Dilli D, Eras Z, Andiran N, Dilmen U, Sakrucu ED. Neurodevelopmental evaluation of very low birth weight infants with transient hypothyroxinemia at corrected age of 18-24 months. Indian Pediatr 2012;49:711-5.   DOI
18 Osborn DA, Hunt RW. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 2007;(1):CD005945.
19 Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007;(1):CD005948.
20 van Wassenaer AG, Briet JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJ, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;110:534-9.   DOI
21 Seth A. Transient hypothyroxinemia of prematurity does it have clinical relevance? Indian Pediatr 2012;49:703-4.   DOI
22 Cuestas RA, Engel RR. Thyroid function in preterm infants with respiratory distress syndrome. J Pediatr 1979;94:643-6.   DOI
23 Lombardi G, Iodice M, Miletto P, Merola B, Panza N, Annunziato L. Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism. Neuroendocrinology 1986;43:676-8.   DOI
24 Williams FL, Ogston SA, van Toor H, Visser TJ, Hume R. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 2005;90:5954-63.   DOI
25 Friedman S, Shinwell ES. Prenatal and postnatal steroid therapy and child neurodevelopment. Clin Perinatol 2004;31:529-44.   DOI
26 Abbassi V, Merchant K, Abramson D. Postnatal triiodothyronine concentrations in healthy preterm infants and in infants with respiratory distress syndrome. Pediatr Res 1977;11:802-4.   DOI
27 Silva SA, Chagas AJ, Goulart EM, Silva GA, Marcal LV, Gomes MN, et al. Screening for congenital hypothyroidism in extreme premature and/or very low birth weight newborns: the importance of a specific protocol. J Pediatr Endocrinol Metab 2010;23:45-52.
28 Mandel SJ, Hermos RJ, Larson CA, Prigozhin AB, Rojas DA, Mitchell ML. Atypical hypothyroidism and the very low birthweight infant. Thyroid 2000;10:693-5.   DOI
29 Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143:587-91.   DOI